nps-568 has been researched along with lanthanum carbonate in 2 studies
| Studies (nps-568) | Trials (nps-568) | Recent Studies (post-2010) (nps-568) | Studies (lanthanum carbonate) | Trials (lanthanum carbonate) | Recent Studies (post-2010) (lanthanum carbonate) |
|---|---|---|---|---|---|
| 162 | 4 | 54 | 390 | 87 | 218 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H | 1 |
| Ben-Dov, IZ; Naveh-Many, T; Nechama, M; Silver, J | 1 |
1 review(s) available for nps-568 and lanthanum carbonate
| Article | Year |
|---|---|
CKD-MBD: impact on management of kidney disease.
Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins | 2007 |
1 other study(ies) available for nps-568 and lanthanum carbonate
| Article | Year |
|---|---|
Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD.
Topics: 3' Untranslated Regions; Adenine; Aniline Compounds; Animals; Calcium; Chronic Disease; Disease Models, Animal; Half-Life; Hyperparathyroidism, Secondary; Kidney Diseases; Lanthanum; Male; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Phosphates; Phosphorus, Dietary; Propylamines; Rats; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Time Factors; Trans-Activators | 2009 |